Results 221 to 230 of about 348,423 (344)
Clinical Pharmacology &Therapeutics, EarlyView.A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner +13 more
wiley +1 more source
Uncovering the tacit: a qualitative study of obstetric nurses' risk recognition and decision-making in perinatal care. [PDF]
Front Med (Lausanne)Zhang S, Chen Y, Hua L, He Y, Zhang L.
europepmc +1 more source
Major Adverse Cardiac Events with Ondansetron: A Systematic Review
Clinical Pharmacology &Therapeutics, EarlyView.Evidence base: 170 randomized trials, 23,421 adults, predominantly single‐dose IV ondansetron, mean follow‐up 20 days. Observed outcomes: Major adverse cardiac events were rare, no ventricular arrhythmias or torsades de pointes observed. Conclusion: Ondansetron was not associated with increased mortality or serious cardiac arrhythmias in adult ...
Michael Cristian Garcia +11 more
wiley +1 more source
Corrigendum to "Author's response to Letter to the Editor re: Paz-Ilbarra C-ZM et al. A giant parathyroid cyst causing primary hyperparathyroidism in a pregnant woman: Case report and literature review". [PDF]
Obstet Medeuropepmc +1 more source
Appendectomy During Pregnancy and the Risk of Preterm Birth: A Systematic Review of Contemporary Clinical Studies. [PDF]
J Clin MedCostescu S +6 more
europepmc +1 more source